This cell line model adeptly mimics the hallmark features of the NAFLD phenotype, demonstrating how the upregulated Smpd3/nSMase2 expression/activity could contribute to hepatic lipid accumulation, inflammation, oxidative stress, and apoptosis. Here, SMPD3 is linked to metabolic dysfunction-associated steatotic liver disease.